IA
GOSS icon

IFP Advisors’s Gossamer Bio GOSS Stock Holding History

IFP Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$913 Sell
5,545
-298
-5% -$83 ﹤0.01% 4525
2026
Q1 		$1.92K Buy
5,843
+4,898
+518% +$7.7K ﹤0.01% 3979
2025
Q4 		$2.93K Buy
945
+786
+494% +$2.24K ﹤0.01% 3694
2025
Q3 		$418 Buy
+159
New +$350 ﹤0.01% 4231
2020
Q4 		– Sell
-3
Closed -$30 – 2998
2020
Q3 		$0 Buy
+3
New +$40 ﹤0.01% 2900

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

IFP Advisors's GOSS Position: Q2 2026 in Review

IFP Advisors reduced its Gossamer Bio (GOSS) stake by 5.1% in Q2 2026, selling an estimated $83 and leaving 5,545 shares worth $913. The position accounts for ﹤0.01% of the portfolio, ranked #4525.

IFP Advisors first reported a position in GOSS in Q3 2020 and has held it in 5 quarters since. The position peaked at $2.93K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • IFP Advisors held 5,545 shares of Gossamer Bio worth $913 as of Q2 2026.
  • IFP Advisors sold 298 Gossamer Bio shares in Q2 2026, an estimated $83.
  • Gossamer Bio made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4525 holding.
  • IFP Advisors first reported a position in Gossamer Bio in Q3 2020 and has held it in 5 quarters since.
  • IFP Advisors's Gossamer Bio position peaked at $2.93K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.